Organization
Lapix Therapeutics
1 clinical trial
Clinical trial
A Phase I First in Human, Randomized, Double-blind, Placebo- Controlled Study in Healthy Adult Volunteers to Evaluate Safety, Tolerability and Pharmacokinetics of LPX-TI641 After Single Oral Doses.Status: Recruiting, Estimated PCD: 2024-04-15